๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Amino Acid Substitution in HCV Core/NS5A Region and Genetic Variation Near IL28B Gene Affect Treatment Efficacy to Interferon plus Ribavirin Combination Therapy

โœ Scribed by Akuta, Norio; Suzuki, Fumitaka; Hirakawa, Miharu; Kawamura, Yusuke; Sezaki, Hitomi; Suzuki, Yoshiyuki; Hosaka, Tetsuya; Kobayashi, Masahiro; Kobayashi, Mariko; Saitoh, Satoshi


Book ID
111891835
Publisher
S. Karger AG
Year
2012
Tongue
English
Weight
837 KB
Volume
55
Category
Article
ISSN
0300-5526

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Randomized trial of high-dose interferon
โœ Nami Mori; Michio Imamura; Yoshiiku Kawakami; Hiromi Saneto; Tomokazu Kawaoka; S ๐Ÿ“‚ Article ๐Ÿ“… 2009 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 275 KB ๐Ÿ‘ 1 views

## Abstract The aim of this study was to compare the efficacy of highโ€dose interferon (IFN)โ€ฮฑโ€2b with standard dose of IFNโ€ฮฑโ€2b in combination with ribavirin (RBV) for patients with chronic hepatitis C virus (HCV) infection, and to investigate the predictive factors associated with virological resp

Amino acid substitution in hepatitis C v
โœ Norio Akuta; Fumitaka Suzuki; Miharu Hirakawa; Yusuke Kawamura; Hiromi Yatsuji; ๐Ÿ“‚ Article ๐Ÿ“… 2010 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 213 KB ๐Ÿ‘ 2 views

Genetic variation near the IL28B gene and substitution of amino acid (aa) 70 and 91 in the core region of hepatitis C virus (HCV) genotype 1b can predict the response to pegylated interferon (PEG-IFN)/ribavirin combination therapy, but its impact on triple therapy of telaprevir/PEG-IFN/ribavirin is